The rating affirmation was supported by a number of factors, including Excela’s improved operating performance over the last 18 months and strong balance sheet ratios for the “A3” rating category.
The system also faces some challenges, which were considered for the rating affirmation, such as having high Medicare volumes.
The revision of the outlook to stable was based on Excela’s improved operating performance, low debt load and strong liquidity.
More articles on healthcare finance:
Geisinger admissions rise, net income falls
Moody’s to join EMMA later this year
CMS launches network to facilitate Medicare payment overhaul
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
